Study calls for tailored treatments for regional HIV variations
|
In the absence of a vaccine, injectable antibodies are
currently being tested as a way to prevent HIV infection. A vaccine
triggers the body's immune ... |
Merck's Investigational Drug Could Bring a Once-Monthly Oral Option for HIV PrEP
... HIV drugs currently under investigation. The drugmaker also is researching the other novel drug in this class, islatravir, which is undergoing ... View article...